2025-12-06 - Analysis Report
Okay, let's break down the UNH (UnitedHealth Group) analysis based on the provided data.

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health benefits and healthcare services.

**1) Return Rate Comparison with S&P 500 (VOO):**

*   **UNH Cumulative Return:** -15.91%
*   **VOO Cumulative Return:** 100.58%
*   **Divergence:** -120.4
*   **Relative Divergence:** 6.2

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) over the period represented by this data.  The divergence is a substantial negative value (-120.4), indicating a large difference in cumulative returns. The relative divergence of 6.2 suggests that this divergence is near the lower end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha  | Beta | Cap(B) |
|------------|---------|---------|--------|------|--------|
| 2015-2017  | 58.0%   | 66.4%   | 30.0%  | 0.1  | 194.5  |
| 2016-2018  | 41.0%   | 70.4%   | 26.0%  | 0.1  | 219.8  |
| 2017-2019  | 36.0%   | 73.8%   | 14.0%  | 0.2  | 259.4  |
| 2018-2020  | -43.0%  | 81.2%   | -67.0% | 0.5  | 309.4  |
| 2019-2021  | 16.0%   | 81.2%   | -30.0% | 1.5  | 443.0  |
| 2020-2022  | -1.0%   | 81.2%   | 0.0%   | 1.5  | 467.8  |
| 2021-2023  | 24.0%   | 80.8%   | 23.0%  | 0.4  | 464.5  |
| 2022-2024  | -27.0%  | 78.8%   | -47.0% | 0.3  | 446.3  |
| 2023-2025  | -58.0%  | 79.8%   | -123.0% | 1.2  | 299.7  |

**Analysis:**

*   **CAGR Trend:** CAGR has been highly variable, including significant negative values in recent periods.
*   **MDD:**  Maximum Drawdown is consistently high, indicating significant volatility.
*   **Alpha:** Alpha has become significantly negative recently, suggesting UNH has underperformed relative to its expected return based on its risk (Beta).
*   **Beta:** Beta has fluctuated, with recent periods showing higher Beta values, indicating increased sensitivity to market movements.
*   **Cap(B):** Market capitalization shows a decline in the most recent period.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 339.71
*   **Last Market Data:** Price: 330.94, Previous Close: 333.49, Change: -0.76
*   **5-day SMA:** 331.22
*   **20-day SMA:** 324.61
*   **60-day SMA:** 342.84

**Analysis:** The stock price has recently declined, indicated by the negative change in the last market data. The 5-day SMA is above the 20-day SMA, suggesting a short-term upward trend, while both are below the 60-day SMA, suggesting a longer-term downward trend or consolidation.

**3) RSI, PPO, and Hybrid Signal:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 50.45 (Neutral)
*   **PPO:** 0.81 (Positive)
*   **Hybrid Signal:** Buy 100% of cash
*   **Recent Relative Divergence Change:** -5.1 (Short-term Decline)
*   **Expected Return:** -283.2% (Significantly Negative)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is close to neutral, indicating neither overbought nor oversold conditions.
*   PPO is positive, implying that the short-term moving average is above the long-term moving average, indicating a potential uptrend.
*   The hybrid signal recommends buying, despite other negative indicators.
*   The recent decline in relative divergence reinforces the short-term bearish trend.
*   The expected return is extremely negative, suggesting poor long-term prospects based on the current analysis.

**4) Recent News & Significant Events:**

The recent news headlines are mixed:

*   Some articles suggest a buy opportunity ("Time To Buy This Healthcare Fortress").
*   Others discuss price target upgrades and reasons for recent price increases (Wolfe Research, Motley Fool).
*   Some articles reassess valuation after a rebound.
*   One article questions if it's safe to buy after a 37% increase since August.

**Analysis:** Recent news suggests some positive sentiment around UNH, with analysts upgrading price targets and articles discussing reasons for recent price increases. However, other articles are more cautious, questioning the sustainability of the rally and reassessing valuation.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean of 2.00)
*   **Target Price:** Average 388.52 (Significant upside from current price)

**Analysis:** The analyst consensus is "Buy" with a target price significantly higher than the current price. This suggests analysts are optimistic about UNH's future performance despite recent struggles.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-28 | 2.59 | 113.16 B$    |
| 2025-08-11 | 3.76 | 111.62 B$    |
| 2025-05-07 | 6.9  | 109.58 B$    |
| 2024-11-04 | 6.56 | 100.82 B$    |
| 2025-10-28 | 6.56 | 100.82 B$    |

**Analysis:** Revenue has been generally increasing. EPS has been variable. The latest EPS is lower than previous quarters.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-09-30 | $113.16B   | 18.24%        |
| 2025-06-30 | $111.62B   | 17.93%        |
| 2025-03-31 | $109.58B   | 21.70%        |
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE   |
|------------|------------|-------|
| 2025-09-30 | $95.79B   | 2.45% |
| 2025-06-30 | $94.72B   | 3.60% |
| 2025-03-31 | $95.04B   | 6.62% |
| 2024-12-31 | $92.66B   | 5.98% |
| 2024-09-30 | $94.53B   | 6.41% |

**Analysis:**

*   **Revenue:**  Revenue has generally increased over the past five quarters.
*   **Profit Margin:** Profit margins have decreased in the most recent quarters.
*   **Equity:** Equity has remained relatively stable.
*   **ROE:** ROE (Return on Equity) has decreased significantly, particularly in the latest quarter.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** UNH has significantly underperformed the S&P 500.
*   **Volatility:** High Maximum Drawdown and fluctuating Beta indicate significant volatility.
*   **Negative Alpha:** Recent negative Alpha suggests underperformance relative to risk.
*   **Mixed Signals:** Recent news is mixed, with some positive analyst sentiment but also caution.
*   **Revenue Growth, Margin Decline:** Revenue is growing, but profit margins and ROE are declining.
*   **Short-Term Bearish, Long-Term Uncertain:** Short-term indicators are bearish. The long-term outlook is uncertain given the negative expected return and declining profitability metrics, despite the positive analyst consensus.
*   **Investment Recommendation:** While the hybrid signal suggests buying and the analyst consensus is a buy, the negative cumulative return compared to VOO, declining profitability metrics, negative expected return, and short-term bearish indicators warrant extreme caution. A more conservative approach would be to wait for clearer signs of a turnaround before investing.

In conclusion, the data presents a mixed picture for UnitedHealth Group. While analyst sentiment and some news headlines are positive, underlying financial metrics and performance relative to the market are concerning. A careful evaluation of risk tolerance and a wait-and-see approach may be warranted.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.